Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Americans Spend $34 Billion A Year On Complementary And Alternative Medicine
According to a new report based on a government survey in 2007, in the previous 12 months Americans had spent a total of $33.9 billion out of their own pockets on

Lobbyists Elbow For Attention As Health Reform Votes Loom
The conservative message on health care is that President Obama"s revamp of the health care system in America will produce a costly government-run program that limits patient choice, The Associated Press reports.
News of the day
One In Ten Advanced Colon Cancer Patients Worry About Prescription Drug Costs
The vast majority of advanced colon cancer patients in a clinical trial were not concerned about the cost of prescription drugs for managing chemotherapy side effects, such as infection, pain and nausea and few adopted strategies to reduce drug cost burdens after joining the clinical trial, according to a study led by researchers at Dana-Farber Cancer Institute in Boston. Although few patients reported substantial worry about drug costs, still fewer reported discussing drug cost issues with their physicians, suggesting there are opportunities for improving how physicians integrate discussions about drug costs into clinical practice.
Health Insurance

New Once-daily Treatment For Type 2 Diabetes

A new treatment for Type 2 diabetes has hit the headlines today. Liraglutide (Victoza), a once-daily injectable treatment for Type 2 diabetes, is pharmaceutical company Novo Nordisk"s latest brain child. From the Glucoagon-like peptide-1 (GLP-1) family of drugs, it can be taken any time of day, irrespective of meals. It helps to control Type 2 diabetes by stimulating the release of insulin when blood glucose levels are too high. In addition, makers claim liraglutide aids weight loss by making you feel more full and delaying the rate at which your stomach empties. Studies have also shown that the drug can reduce blood pressure and improve the function of beta cells - the cells that produce insulin in the pancreas. Cathy Moulton, Care Advisor at leading health charity Diabetes UK, said: "Liraglutide widens the choice of treatments for people with Type 2 diabetes that not only offer improved blood glucose control but also aid weight loss. In addition, research has shown that this treatment has a positive effect on blood pressure levels. "Diabetes UK welcomes safe and effective treatments that give people with diabetes choice in how to best manage their condition. In addition to any prescribed medication, people with diabetes should eat a healthy balanced diet and do regular physical activity. Good diabetes management reduces the risk of developing serious complications including heart disease, stroke, kidney failure, blindness and amputation." Diabetes UK


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009